We have reported, for the first time, that the levels of Rab3D are elevated in clinical patient samples with many tumor types including breast, prostate, lung, colon, ovary, liver and skin cancers and are highly correlated with tumor TNM staging. This evidence concerns the gene RAB3D and skin neoplasm.